Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Which High Yield Etf Is Safest For Retirement examines safety indicators and diversification to help retirees select resilient, income-generating ETFs.
26,792 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Alphabet surged more than 70% over the past year, but the question remains: is it too late to buy? This guide looks a...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...
A major investment fund disclosed a $13.93 million exit from a booming AI investment in Q1 2026. Here’s what this mov...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...
Rigetti Computing led gains as quantum optimism returned to the front pages, helping propel the stock market today hi...
Investors are weighing Micron's AI-driven demand against a volatile memory market. This guide breaks down whether you...
An AI-chip IPO like Cerebras can spark excitement and risk in one breath. cerebras opened $350 nearly, blasting past ...